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Aims: This study investigated the effects of indole-3-carbinol (I3C), a compound from cruciferous vegetables, on various
parameters related to obesity, in particular, the parameters of infiltration by macrophages and of inflammatory cytokines
expressed during the co-culture of adipocytes and macrophages.
Methods: Male C57BL/6 mice were fed with a control diet (C group), high-fat diet (HF group) and HFþ5mgkg
 1 I3C (HFI
group). The I3C was intraperitoneally injected (HFI group) for 12 weeks. Epididymal adipose tissue (AT) was collected and
stained for F4/80, a marker of macrophages.
Results: The immunohistochemical staining for F4/80 indicated a greater presence of macrophages in the HF group than in AT
from the control and HFI groups. Furthermore, I3C treatment, in an in vitro cell culture system, decreased expression of inducible
nitric oxide synthase (iNOS), decreased nitrite content and enhanced expression of peroxisome proliferator-activated receptor
(PPAR-g). Moreover, in vitro cell culture studies revealed that I3C inhibited intracellular lipid accumulation in hypertrophied
adipocytes. In macrophage and primary adipocyte co-culture, I3C inhibited expression of interleukin-6 (IL-6).
Conclusions: In vivo treatment with I3C reduced the infiltration of macrophages in AT, and in vitro addition of I3C to co-cultured
macrophages and adipocytes reduced nitrite production and IL-6 expression. With cultures of adipocytes only, I3C inhibited
accumulation of intracellular lipid, either by disrupting differentiation, or by directly inhibiting triglyceride synthesis.
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Introduction
Obesity is accompanied by chronic inflammation. Hyper-
plasia adipocytes will produce numerous mediators, includ-
ing adipokines, associated with adipose tissue (AT)
inflammation, as obesity can induce the release of inflam-
matory cytokines.
1 Chronic inflammation can cause obesity
2
and contributes to an increased risk of type 2 diabetes and
atherosclerosis.
3–6 AT is composed of various cell types,
including mature adipocytes and a stromal vascular fraction
that includes blood cells, endothelial cells and macro-
phages.
7 Adipocytes have recently been classified as mem-
bers of the immune system, as these cells are potent
producers of inflammatory cytokines, such as interleukin-6
(IL-6).
8 Obesity is associated with an increase in number of
macrophages in AT, where this increase in macrophages
could represent either the cause or the consequence of the
low-grade inflammation state associated with obesity.
6,9,10
Macrophage infiltration is associated with the expression
of proinflammatory adipocytokines in obese AT.
11 Thus,
obesity can be characterized as a disorder having an imba-
lance between pro-inflammatory and anti-inflammatory
mediators, and by obesity-induced AT inflammation.
12,13
Adipocytes can express various cytokines, such as leptin,
adiponectin, resistin, tumor necrosis factor-a, IL-6 and
monocyte chemoattractant protein-1 (MCP-1). When secre-
ted by adipocytes and macrophages, these cytokines
modulate inflammation in obese AT.
14,15 Tumor necrosis
factor-a, IL-6 and MCP-1 are inflammatory cytokines that
are commonly elevated in obesity.
9 Therefore, interactions
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www.nature.com/ijobetween macrophages and adipocytes may contribute to the
inflammatory pathology found in obese AT.
16 The following
concerns nitric oxide synthase and nitrite. Chronic inflamma-
tion contributes to obesity-induced insulin resistance. Induci-
ble nitric oxide synthase (iNOS), a mediator of inflammation,
has recently been found to contribute to insulin resistance.
Obesity is associated with increased iNOS expression in insulin-
sensitive tissues in rodents and humans.
17
Cruciferous vegetables contain a number of bioactive
components including glucosinolates and indole-3-carbinol
(I3C). Epidemiology studies showed that a higher consump-
tion of cruciferous vegetables, for example, broccoli, cauli-
flower and brussels sprouts, diminishes the risk of cancer and
cardiovascular diseases.
18,19Although cruciferous vegetables
contain a number of compounds for cancer prevention, I3C
alone shows efficacy for the prevention of breast, endo-
metrial and cervical cancers.
20,21 We have demonstrated that
I3C can suppress lipopolysaccharide-induced iNOS, nitric
oxide, and proinflammatory cytokines in macrophages.
22
We also demonstrated that intraperitoneally injected I3C
reduces body weight in high-fat (HF) diet-induced obesity.
The present study was aimed at investigating the effects of
I3C on macrophage infiltration in obese AT, and on potential
mechanism of inflammatory mediators during the in vitro
co-culture of macrophages and adipocytes.
Materials and methods
Chemicals and biochemicals
I3C with 98% purity, lipopolysaccharide, sulfanilamide,
naphthylethylenediamine dihydrochloride, sodium nitrite,
insulin and collagenase were obtained from Sigma Chemical
(St Louis, MO, USA). Absolute ethanol was from Merck
(Darmstadt, Germany). Dulbecco’s Modified Eagle Medium
and fetal bovine serum were from GIBCO (Grand Island, NY,
USA). I3C was dissolved in absolute ethanol. The concen-
tration of I3C in media was 0.1% (v/v).
Animals and diets
Eighteen 5-week-old male C57BL/6 mice were obtained
from the National Taiwan University Animal Center (Taipei,
Taiwan), and were raised at 22±31C under automatic
lighting cycles. After a 1-week acclimation period, mice were
randomly assigned to three groups: control (C), high fat (HF)
and HFþI3C (HFI). The composition of the diets was a
modified version of the AIN-96M diet used by Jiang et al.
23
The HF diet contained 15.29% of soybean oil and 15.29%
lard as fat (455% of total energy), which induces hyper-
glycemia, hyperinsulinemia, hyperlipidemia and obesity in
animals after 12 weeks of feeding.
I3C was administered intraperitoneally three times per
week on the same weekdays at a dose of 5mgkg
 1 body
weight in a 0.1-ml vehicle containing polyethylene glycol,
benzyl alcohol, ethanol and water (40:0.1:10:49.9),
24 and
animal in both control and HF groups received vehicle
injection only. At the end of the experiment (12 weeks), mice
were sacrificed by cervical dislocation, and epididymal AT
were collected for analysis.
I3C dosage considerations
The I3C dose selected for this study was derived from
previous reports that recorded beneficial outcomes in mice
with 5mgkg
 1, administered by intraperitoneal injection
and without any apparent toxicity.
25,26 For a 60kg human, a
5mgkg
 1 dose equates to a dietary intake of 300mg I3C
obtained by consuming 1800g Chinese cabbage,
27 without
considering losses due to absorption and metabolism in the
body. The clinical administration of I3C at a dosage of
300–400mg daily has been shown to be a safe and effective
chemopreventative oral supplement in females at risk of
developing breast cancer.
28,29 We have, therefore, selected a
dosage in mice that is known to be clinically relevant in
humans. Although drug efficacy is dependent on the route of
administration, mice showed protection against hormone-
induced tumorigenesis when their diet was supplemented
with 70mgkg
 1 I3C (equal to 500 ppm),
30 14 times the
intraperitoneal dosage applied here. This would suggest that
5mgkg
 1 is a very cautious dose.
Immunohistochemistry
Epididymal AT was fixed with 4% paraformaldehyde and
excised, dehydrated in ethanol, and embedded in paraffin.
For immunohistochemistry, the tissue was blocked with 3%
H2O2 and sequentially incubated with anti-mouse F4/80
antibody (Serotec, Raleigh, NC, USA) at 1:100 dilution
in 10% serum for 2h, biotinylated anti-rat IgG (Vector
Laboratories, Burlingame, CA, USA) at 1:200 in 10% serum
for 1h, and streptavidin horseradish peroxidase (Vector
Laboratories, Burlingame, CA, USA) at 1:500 in phosphate-
buffered saline for 20min, with phosphate-buffered saline
washes after each incubation. Sections were incubated with
the 3,30-diaminobenzidine substrate kit (Vector Laboratories,
Burlingame, CA, USA). The tissue was stained with dilute
hematoxylin and then was photographed (Nikon, Japan).
Preparation of primary adipocytes
C57BL/6 male mice (8–12 weeks of age) were anesthetized
and sacrificed, and epididymal AT was collected. The tissues
were cut and incubated with 2% collagenase for 30min at
371C and passed through 40mm filter. After centrifugation at
500 g for 10min, the cell pellet was washed twice with
the culture medium. Cells were seeded at 1 10
6ml
 1 in
each well.
Cell culture
RAW 264.7 cell lines (BCRC 60001) and 3T3-L1 preadipo-
cytes (BCRC 60159) were purchased from Bioresource
Collection and Research Center (Hsinchu, Taiwan). The
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differentiation and AT biology.
31 Primary preadipocytes were
obtained from epididymal AT of C57BL/6 mice. The cells
were cultured in Dulbecco’s modified essential medium
containing 10% fetal bovine serum at 371Ci n5 %C O 2. For
induction of preadipocyte differentiation, primary preadipo-
cytes were incubated in a medium containing insulin (INS),
dexamethasone, and 3-isobutyl-1-methyl-xanthine as de-
scribed previously.
32 The preadipocytes were differentiated
into lipid-laden mature adipocytes (primary adipocytes), and
cultured up to the fourteenth day.
Adipocytes and macrophages co-culture model
Co-culture of primary adipocytes and macrophages was
performed as described.
14 In the co-culture model, macro-
phages (10
6 cells) were plated into hypertrophied primary
adipocytes (10
6 cells). The cells were cultured for 24h and
treated with various concentrations of I3C for 24h. The
supernatants and total RNA of co-cultured cells were
collected in each experiment.
Measurements of nitrite production
The nitrite concentration in the culture medium was
determined as an index of nitric oxide production. Nitrite
was quantified spectrophotometrically after its reaction with
Griess reagent (1:1 mixture of 1% sulfanilamide/ 5% H3PO4
and 0.1% naphthylethylenediamine dihydrochloride) using
sodium nitrite as a substrate.
33
Measurement of IL-6
The culture medium concentration of IL-6 was measured
with an enzyme-linked immunosorbent assay kit (R&D
Systems, Minneapolis, MN, USA), according to the manu-
facturer’s protocols.
Reverse transcriptase polymerase chain reaction analysis
Reverse transcriptase polymerase chain reaction was used to
determine the in vitro effects of I3C on the expression of
lipogenesis-related genes. Total RNA was extracted from
co-culture cells by using TRIzol Reagent (Invitrogen Life
Technologies, Carlsbad, CA, USA), according to the manu-
facturer’s instructions. After the quality was validated by
denaturing agarose gel, the RNA was subjected to reverse
transcription to obtain cDNA. In brief, 2mg total RNA was
incubated with Super Script b (Invitrogen Life Technologies,
Carlsbad, CA, USA), dNTP, oligo-dT, dithiothreitol and
reaction buffer at 371C for 60min. The obtained cDNA
(2ml) was then subjected to PCR, which consisted of
denaturation at 941C for 45s, annealing at 601C for 60s
and elongation at 721C for 60s for 32 cycles. The last
cycle was ended by 10min of elongation at 721C. The
following primers were used: beta-actin, 50-AGCCATGTACG
TAGCCATCC-30 (forward), 50-CTCTCAGCTGTGGTGGTGAA-30
(reverse), 228bp; peroxisome proliferator-activated receptor
(PPAR-g), 50-GTTCATGCTTGTGAAGGATGC-30(forward), and
50-ACTCTGGGTTCAGCTGGTCG-30 (reverse), 250bp; iNOS,
50-CCCTTCCGAAGTTTCTGGGAGGAGC-30 (forward), 50-GG
CTGTCAGAGAGCCTCGTGGCTTTGG-30 (reverse), 497bp;.
The PCR products were then separated by agarose gel, and
the images were visualized and quantified by using the
Image-pro Plus program (Media Cybernetics Inc., Bethesda,
MD, USA).
Oil red O staining of 3T3-L1 adipocytes
The 3T3-L1 cell line is widely used as a model of adipocyte
differentiation and adipose biology.
31 These cells were
exposed to various concentrations of I3C, with the goal of
inducing differentiation to hypertrophied-3T3-L1 adipo-
cytes. Intracellular lipid accumulation, which was a marker
of adipocyte differentiation and adipogenesis, was deter-
mined by using oil red O. The oil red O dye was prepared as
described by Ramirez-Zacaruas et al.
34 Triglyceride concen-
trations were analyzed by using Randox TRIGS (Cat TG213)
assay kits (Randox Labs, Crumlin, UK), and measured by
using an automatic microplate reader (VersaMax, Sunnyvale,
CA, USA).
Statistical analysis
All data are presented as mean±s.d. One-way analysis
of variance was used to compare the differences in body
weight, weight of organs and F4/80 marker expression in
response to the various types of diet. Also, analysis of
variance test was performed to confirm the differences in
nitrite expression, level of IL-6 and triglyceride accumulation
among four co-culture groups. When statistical results
were revealed by analysis of variance, Tukey’s post hoc
test was used to determine post hoc differences. If the
standard deviations for each group were not equal, Dunnett’s
T3 post hoc test was used. The difference between two non-
co-culture group and co-culture group without I3C was
verified with an independent t-test. Differences were con-
sidered statistically significant when Po0.05. All statistics
were two-sided and performed using SPSS 15.0 software (SPSS
Inc., Chicago, IL, USA).
Results
Effect of I3C on macrophage infiltration in AT, body weight and
weight of organ
As Table 1 shows, regardless of type of diet, baseline body
weight of rats in three groups was similar (P¼0.984);
however, the body weight at week 12 in the HF group was
significantly higher than that in the control diet group
(Po0.001), and the body weight at week 12 in the I3C-
treated HF group (HFI) was significantly lower than that in
the HF group (Po0.001). The HF group also had higher
weight of liver than the HFI group (P¼0.028). The weight of
AT was significantly higher in both HF (Po0.001) and HFI
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and was significantly lower in the HFI group as compared
with the HF group (P¼0.022).
Effects of I3C on macrophage infiltration in AT
AT during obesity is characterized by increased infiltration
by macrophages. After the animals were fed the different
diets for 12 weeks, histological examination using anti-F4/80
antibodies revealed appreciable positive staining in epidi-
dymal AT of mice fed with HF. However, there was no
significant difference in the AT between the control group
and the HFI group (Figure 1 and Table 1). The macrophage-
specific marker, F4/80, is expressed significantly higher in
the HF group as compared with the control diet group
(P¼0.001), and significantly lower in the HFI group as
compared with the HF group (P¼0.004). The similar levels of
F4/80 in the control group and HFI group indicate that I3C
prevents HF-induced infiltration by macrophages.
Effects of I3C on inflammatory mediators in adipocytes
co-culture with macrophages
Differentiated adipocytes were co-cultured with RAW 264.7
cells for 24h and then treated with I3C (zero to 100mM) for
24h. As shown in Figure 2a, the nitrite decreased as the
concentration of I3C increased (Po0.001). The I3C treat-
ment suppressed nitrite by 62.3% at 100mM I3C, 15.9% at
10mM, 6.0% at 1mM compared with no I3C added. In primary
adipocytes or RAW macrophages cultured alone, the con-
centration-response inhibitive effect of I3C on nitrite
release was not evident (Figure 2a). Interestingly, the nitrite
production was dramatically increased during the co-culture
of adipocytes and macrophage compared with the two cells
cultured alone (Figure 2a).
We also investigated the effect of I3C on expression of
iNOS mRNA in co-culture of adipocytes and macrophages by
reverse transcriptase polymerase chain reaction (Figure 2b).
The level of iNOS mRNA expression changed downward as
the concentration of I3C increased (P¼0.001). The level of
iNOS mRNA expression at concentration¼10mM was lower
than at concentration¼0mM (P¼0.038), and the level of
iNOS mRNA expression at concentration¼100mM was lower
than at other concentrations (Po0.01). The results indicate
that the treatment of I3C reduced expression of iNOS.
A strong effect was found from measuring IL-6 expression.
High expression of IL-6 was detected when adipocytes were
co-cultured with RAW 264.7 macrophages (Figure 3). Expres-
sion of IL-6 was reduced by adding I3C in a concentration-
dependent manner. Added I3C suppressed the level of IL-6
by 21.1% at 10mM I3C (P¼0.008) and 41.6% at 100mM I3C
(Po0.001), respectively. However, the expression of IL-6 in
primary adipocytes or RAW 264.7 macrophages was very low
when cultured alone, with or without I3C treatment
(Figure 3), which was less responsive to I3C.
Effects of I3C on the expression of PPAR-g mRNA
The expression of PPAR-g was examined by reverse tran-
scriptase polymerase chain reaction (Figure 4a). As shown in
Figure 4b, I3C stimulated the relative expression of PPAR-g
mRNA in adipocytes co-cultured with macrophages (com-
pared with I3C¼0, Po0.001). Even though PPAR-g mRNA
expression increased gradually as a function of I3C concen-
tration, differences in the level of expression were not
significant in response to 1, 10 or 100mM I3C.
Effects of I3C on intracellular lipid accumulation
We next measured adipogenesis, and determined whether
adipogenesis is affected by I3C in 3T3-L1 cells. The 3T3-L1
cell line is widely used as a model of adipocyte differentia-
tion and adipose biology.
31 After differentiation, the mature
3T3-L1 adipocytes accumulated larger intracellular droplets
than the undifferentiated preadipocytes. Histological results
demonstrated that I3C reduced the content of intracellular
triglyceride in 3T3-L1 adipocytes (Figure 5a). The data are
summarized in Figure 5b. Triglyceride accumulation was
curtailed from 171.3% at concentration¼0mM, 139.2% at
concentration¼1mM to 98.1% at concentration¼10mM.
Although the triglyceride accumulation increased slightly
between concentration¼10mM and concentration¼100mM,
the change was not significant (P¼0.434). I3C treatment
resulted in a reduction in intracellular triglyceride accumula-
tion, which was similar in extent to the reduction seen for
inflammatory cytokines (Figure 3).
Discussion
In the present study, we demonstrated that I3C reduces
macrophage accumulation in obese AT and also reduces
Table 1 Body weight, weight of organs and F4/80 expression
Control diet
(n¼6)
High fat
(n¼6)
High fat+I3C
(n¼6)
P-value
a
Body weight (g)
Baseline 21.7±0.5 21.6±1.6 21.6±1.8 0.984
Week 12 26.6±1.0 34.4±2.1
c 28.3±2.0
d o0.001
b
Organ weight (g)
EAT 0.50±0.11 1.81±0.60
c 1.18±0.15
c,d o0.001
b
Liver 0.95±0.10 1.05±0.08 1.10±0.07
c 0.032
b
Heart 0.47±0.08 0.42±0.08 0.42±0.08 0.454
Kidney 1.13±0.10 1.02±0.12 1.05±0.08 0.160
Spleen 0.28±0.08 0.23±0.05 0.25±0.05 0.381
Relative F4/80
expression (divided
by b-actin expression)
1.0 10.8±2.8
c 3.2±0.8
d 0.019
b
Abbreviation: EAT, epididymal adipose tissue.
aData were presented as mean±standard deviation and tested by ANOVA.
Tukey’s test or Dunnett’s T3 test was used for post-hoc tests.
bSignificantly
different among three groups, Po0.05.
cSignificantly different from control
diet group, Po0.05.
dSignificantly different from high fat group, Po0.05.
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co-cultured adipocytes and macrophages. Obese AT is
characterized by an enhanced-macrophage infiltration. In
white AT, the F4/80 marker for macrophages was predomi-
nantly expressed in the stromal vascular fraction where
macrophages reside. We have found that the macrophage-
specific marker, F4/80, is dramatically upregulated in white
AT of obese mice, indicating an increase in macrophage
infiltration in this tissue, and that administering I3C reduced
macrophage infiltration. Obese AT is characterized by the
infiltration of macrophages, and these macrophages are an
important source of inflammation in that tissue.
10 Dandona
et al.
35 indicated that white AT inflammation may be
potential mechanism by which obesity leads to insulin
resistance. Diet-induced obesity is associated with adipocyte
hypertrophy and macrophage infiltration. We found that
I3C can reverse the accumulation of white AT macrophages
in obese AT, which contributes to the chronic inflammation
response of obesity.
The co-culture system provides a unique in vitro experi-
mental system to assess the expression of inflammatory
markers, arising from interactions between adipocytes and
macrophages. Additionally, an increased number of macro-
phages resident in human AT has been reported in obesity.
This increase is expected to contribute to inflammatory
processes by the macrophage’s expression of pro-inflamma-
tory cytokines such as tumor necrosis factor-a, IL-6 and
MCP-1.
36 In the present study, the data showed that the co-
culture of hypertrophied adipocytes and RAW 264.7 macro-
phages stimulated the production of proinflammatory
mediators, nitrite and IL-6, a finding consistent with a
previous report.
16 Compounds from cruciferous vegetables,
such as I3C, have been demonstrated to have anti-
cancer and anti-inflammation properties.
37 Recently, we
C
HF
HFI HFI
HF
C
Figure 1 Effects of I3C on F4/80 expression in epididymal adipose tissue (AT),  200 magnification (a)a n d 400 magnification (b), in animals fed different diets
for 12 weeks (C, control diet; HF, high-fat diet; HFI, high-fat dietþintraperitoneally administered I3C). Immunohistochemistry detected a macrophage-specific
antigen (F4/80) in epididymal AT from high-fat diet-induced obese mice. The black arrows showed abundant macrophages within AT. Macrophages were observed
both near blood vessels and among large adipocytes. The scale bar represents 100mm.
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duced iNOS, nitric oxide and proinflammatory cytokines.
22
Obese subjects demonstrated higher levels of MCP-1 gene
expression.
38 Although MCP-1 expression from primary
adipocytes co-cultured with macrophages was measured in
response to I3C, the effects were marginal and failed to
demonstrate a significant concentration-response effect
(data not shown). Because MCP-1 is expressed by adipocytes
and has an important role in monocyte recruitment, it is
possible that obesity-related adipocyte expression of MCP-1
results in the recruitment of resident monocytes, which then
elaborate inflammatory cytokines, resulting in insulin
resistance and many of the features of metabolic syndrome.
These observations suggested that I3C ameliorated in
obese-induced AT inflammation by macrophages, both
in vivo and in vitro.
We also found that I3C inhibited nitrite content and iNOS
mRNA expression in adipocytes cultured with macrophages,
revealing the inhibitory effect of I3C on nitric oxide
production is associated with suppressed iNOS mRNA
expression. Only the highest concentrations of I3C that
were used in the present study had the effect of decreasing
nitrite production. Furthermore, I3C can elevate PPAR-g
mRNA expression. PPAR-g is involved in inflammatory
response. Currently, the mechanisms of PPAR-g have anti-
inflammatory actions via interference with proinflammatory
transcription factors, including NFkB and AP-1.
39 Previously
studies showed that NFkB is one of transcription factors that
regulate the gene expression of MCP-1, IL-6, tumor necrosis
factor-a and iNOS.
40,41 Furthermore, inactivation of the
nuclear factor-kB pathway, which induces inflammatory
mediators, has led to the protection against insulin resis-
tance.
42 These findings suggested that I3C may be used
for protecting against the development of obesity-related
sequelae, by reducing nitrite production, by inhibiting the
expression of inflammatory cytokines by macrophages or
by adipocytes and by modulating the expression of PPAR-g.
Providing I3C to cultured cells, in vitro, inhibited adipo-
genesis into differentiated adipocytes. The prevalence of
obesity and obesity-related disorders has led to increased
focus on the influence of AT mass. The adipocyte is the
major site for energy storage and accumulates triglycerides
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Figure 2 Effects of I3C on nitrite content and inducible nitric oxide synthase
(iNOS) mRNA expression in co-culture of primary adipocytes and macro-
phages. Differentiated adipocytes were co-cultured with RAW 264.7 macro-
phages (1 10
6cells per well) or the cells were cultured alone (a) and cells
were treated with I3C (mM) for 24h. Nitrite levels were spectrophotometrically
measured with Griess reagent. Expression of iNOS mRNA (b) was measured by
reverse transcriptase polymerase chain reaction. Values are the mean±s.d.
from six measurements. Values with different superscript letters (a, b and c)
indicate significant differences between groups (Po0.05).
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Figure 3 Effects of I3C on interleukin-6 (IL-6) in co-culture of primary
adipocytes and macrophages. Differentiated adipocytes were co-cultured with
RAW 264.7 macrophages (1 10
6cells per well), and cells were treated with
I3C (mM) for 24h. IL-6 contents in the co-culture model, primary adipocytes
alone and RAW 264.7 macrophages alone, were measured by ELISA. Values
are the mean±s.d. from six measurements. Values with different superscript
letters (a, b and c) indicate significant differences between groups (Po0.05).
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secrete lower levels of inflammatory markers than larger
adipocytes.
43 Moreover, inhibition of adipogenesis in
3T3-L1 adipocytes by certain phytochemicals resulted from
the down-regulated expression of adipogenic transcription
factors, such as PPAR-g and C/EBPa.
44,45 However, I3C
treatment reduced intracellular triglyceride accumulation
and the expression of inflammatory mediators regulated by
adipocyte-specific transcription factors, to a similar extent.
The obesity-related symptoms were therefore improved by
the I3C treatment. Whether I3C inhibits adipogenesis by
disrupting differentiation, or by directly suppressing tri-
glyceride synthesis, is not clear from our studies, as changes
in 3T3-L1 adipocyte differentiation were not measured. It
has been established that PPAR-g can positively regulate
adipose triglyceride lipase, thereby promoting the break-
down of triglycerides.
46 In response to I3C, the lowered
triglyceride accumulation is, therefore, consistent with the
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Figure 4 Effects of I3C on peroxisome proliferator-activated receptor (PPAR-
g) mRNA in co-culture of primary adipocytes and macrophages. Differentiated
adipocytes were co-cultured with RAW 264.7 macrophages (1 10
6cells per
well), and cell treated with I3C for 24h. Differentiated adipocytes were treated
with ethanol (0mM I3C), 1mM I3C, 10mM I3C or 100mM I3C, as indicated. The
expression of PPAR-g mRNAs was determined by reverse transcriptase
polymerase chain reaction. The total cellular RNA was isolated and reverse-
transcribed to cDNA (a). The relative expression of PPAR-g under different
concentrations of I3C was summarized (b). These experiments were repeated
three times. Values with different superscript letters (a and b) indicate
significant differences between groups (Po0.05).
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Figure 5 Effects of I3C on intracellular lipid accumulation (a) and
triglyceride accumulation (TG) content (b) in 3T3-L1 adipocytes. 3T3-L1
were differentiated by culturing with adipogenic agent. Cells were treated
with various concentrations of I3C for 72h. Cells were stained with oil
red O. TG contents were quantified by a commercial assay kit, as described
in Materials and Methods. These experiments were repeated three times,
and similar results were obtained. Control: undifferentiated 3T3-L1 preadipo-
cytes; 0 (0mM I3C): differentiated 3T3-L1 adipocytes treated with
ethanol; 1–100mM: differentiated adipocytes treated with 1–100mM I3C.
Values are the mean±s.d. from three measurements. Values with different
superscript letters (a, b, and c) indicate significant differences between
groups (Po0.05).
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I3C is inhibiting triglyceride synthesis directly.
To conclude, this study demonstrated the inhibitory effect
of I3C on the expression of inflammatory cytokines, such as
IL-6, by adipocytes or by macrophages, in the co-culture
model, and that the inhibitory effect requires the presence of
both types of cells (adipocytes and macrophages). This study
also demonstrated that I3C inhibits production of inflam-
matory mediator, nitrite, in the co-culture model, as well as
adipogenesis in cultured 3T3-L1 adipocytes. One possible
mechanism mediating the anti-inflammatory effects of I3C
may be inhibition of macrophage-induced inflammatory
changes due to PPAR-g activation. The taking of I3C as a
dietary supplement or even as a prescribed drug in the
future, may be a useful phytochemical for suppressing
chronic inflammation in obese AT, and preventing obesity-
related diseases.
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